These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 421728)

  • 1. Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.
    Ala-Hurula V; Myllylä VV; Arvela P; Heikkilä J; Kärki N; Hokkanen E
    Eur J Clin Pharmacol; 1979 Feb; 15(1):51-5. PubMed ID: 421728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.
    Ibraheem JJ; Paalzow L; Tfelt-Hansen P
    Br J Clin Pharmacol; 1983 Dec; 16(6):695-9. PubMed ID: 6419759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pharmacodynamic effects and plasma levels of oral and rectal ergotamine.
    Bülow PM; Ibraheem JJ; Paalzow G; Tfelt-Hansen P
    Cephalalgia; 1986 Jun; 6(2):107-11. PubMed ID: 3091257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal routes of administration of ergotamine tartrate in cluster headache patients. A pharmacokinetic study.
    Ekbom K; Krabbe AE; Paalzow G; Paalzow L; Tfelt-Hansen P; Waldenlind E
    Cephalalgia; 1983 Mar; 3(1):15-20. PubMed ID: 6406071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of ergotamine in migraine and cluster headache.
    Perrin VL
    Clin Pharmacokinet; 1985; 10(4):334-52. PubMed ID: 3899452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo disposibility of caffeine and ergotamine tartrate after rectal administration].
    Regazzi MB; Rondanelli R; Calvi M; Brè E; Restelli E
    Farmaco Prat; 1985 Aug; 40(8):259-65. PubMed ID: 3928400
    [No Abstract]   [Full Text] [Related]  

  • 7. Low biological availability of ergotamine tartrate after oral dosing in cluster headache.
    Ekbom K; Paalzow L; Waldenlind E
    Cephalalgia; 1981 Dec; 1(4):203-7. PubMed ID: 6812961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergotamine in plasma and CSF after i.m. and rectal administration to humans.
    Hovdal H; Syversen GB; Rosenthaler J
    Cephalalgia; 1982 Sep; 2(3):145-50. PubMed ID: 7151147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular ergotamine: plasma levels and dynamic activity.
    Tfelt-Hansen P; Paalzow L
    Clin Pharmacol Ther; 1985 Jan; 37(1):29-35. PubMed ID: 3917386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.
    Ala-Hurula V; Myllylä VV; Arvela P; Kärki NT; Hokkanen E
    Eur J Clin Pharmacol; 1979 Nov; 16(5):355-60. PubMed ID: 520404
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.
    Ibraheem JJ; Paalzow L; Tfelt-Hansen P
    Eur J Clin Pharmacol; 1982; 23(3):235-40. PubMed ID: 7173294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergotamine-induced solitary rectal ulcer.
    Shpilberg O; Ehrenfeld M; Abramowich D; Samra Y; Bat L
    Postgrad Med J; 1990 Jun; 66(776):483-5. PubMed ID: 2120688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral doses.
    Ala-Hurula V; Myllylä VV; Arvela P; Kärki NT; Hokkanen E
    Ups J Med Sci Suppl; 1980; 31():7-9. PubMed ID: 6935862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergotamine absorption and toxicity.
    Orton DA; Richardson RJ
    Postgrad Med J; 1982 Jan; 58(675):6-11. PubMed ID: 7088766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proctomucosectomy and colo-anal anastomosis in rectovaginal fistula following the use of suppositories containing ergotamine].
    Schwab A; Werthmann K; Merkle P; Thiele HH
    Chirurg; 1988 Jun; 59(6):432-4. PubMed ID: 3144448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine.
    Ala-Hurula V
    Eur J Clin Pharmacol; 1982; 21(5):397-402. PubMed ID: 7075645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of an ampicillin suppository (KS-R1) in adults and children].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
    Jpn J Antibiot; 1983 Jul; 36(7):1713-68. PubMed ID: 6655809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT
    Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of the biological effect of ergotamine tartrate.
    Tfelt-Hansen P; Eickhoff JH; Olesen J
    Adv Neurol; 1982; 33():315-9. PubMed ID: 6798849
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non-tropical sprue and chronic inflammatory rectal stenosis in a patient with abuse of ergotamine-containing suppositories].
    Himmelreich G; Riess H; Kretschmer R; Hopf U
    Z Gastroenterol; 1991 Jan; 29(1):31-5. PubMed ID: 1905444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.